CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 176 filers reported holding CLOVIS ONCOLOGY INC in Q4 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $370,000 | +138.7% | 310,123 | +259.6% | 0.00% | – |
| Q2 2022 | $155,000 | -37.8% | 86,243 | +35.9% | 0.00% | -100.0% |
| Q3 2019 | $249,000 | -61.7% | 63,476 | +75.4% | 0.00% | -71.4% |
| Q4 2018 | $650,000 | -23.2% | 36,184 | +25.7% | 0.01% | +75.0% |
| Q3 2018 | $846,000 | -44.4% | 28,794 | +55.1% | 0.00% | -94.4% |
| Q3 2017 | $1,522,000 | +163.8% | 18,567 | +202.3% | 0.07% | +184.0% |
| Q2 2017 | $577,000 | -84.4% | 6,141 | -92.6% | 0.02% | +4.2% |
| Q4 2016 | $3,687,000 | -38.3% | 83,014 | -49.9% | 0.02% | -42.9% |
| Q3 2016 | $5,975,000 | +691.4% | 165,737 | +1919.2% | 0.04% | +366.7% |
| Q3 2015 | $755,000 | +257.8% | 8,208 | +76.8% | 0.01% | +200.0% |
| Q3 2014 | $211,000 | – | 4,642 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $45,630,648,000 | 43.63% |
| EcoR1 Capital, LLC | 384,348 | $21,523,000 | 10.89% |
| Palo Alto Investors LP | 2,102,857 | $117,760,000 | 6.91% |
| NEA Management Company, LLC | 2,279,781 | $127,668,000 | 6.19% |
| Redmile Group, LLC | 721,632 | $40,411,000 | 4.40% |
| Opaleye Management Inc. | 140,000 | $7,840,000 | 3.96% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 790,555 | $44,271,000 | 2.63% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 339,327 | $19,002,000 | 2.31% |
| PFM Health Sciences, LP | 1,725,126 | $96,607,000 | 2.26% |
| HARBOURVEST PARTNERS LLC | 51,037 | $2,858,000 | 1.50% |